Cerebral Palsy Research Program Authorization Act of 2023

Bill 118 hr 1280, also known as the Cerebral Palsy Research Program Authorization Act of 2023, is a piece of legislation introduced in the US Congress with the aim of authorizing funding for research programs focused on cerebral palsy. Cerebral palsy is a neurological disorder that affects movement and coordination, and there is currently no cure for the condition.

The bill seeks to establish a research program specifically dedicated to studying cerebral palsy in order to better understand the causes of the disorder, improve treatment options, and ultimately find a cure. The program would be overseen by the National Institutes of Health (NIH) and would involve collaboration with other federal agencies, as well as with private organizations and research institutions.

If passed, the bill would authorize funding for the research program for a period of five years, with the goal of advancing scientific knowledge and improving outcomes for individuals living with cerebral palsy. The legislation emphasizes the importance of including individuals with cerebral palsy in the research process, as well as promoting collaboration and information sharing among researchers and healthcare providers. Overall, the Cerebral Palsy Research Program Authorization Act of 2023 represents a bipartisan effort to address the needs of individuals with cerebral palsy and to support research efforts aimed at improving their quality of life.